#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16258	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2560	783.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1663	1663	C	1031	C	1031	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26890	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4039	830.4	0	.	n	.	0	T695C	SNP	695	695	T	1269	1269	C	1037	C,G,A	1030,4,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26890	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4039	830.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1911	1911	A	1146	A	1146	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26890	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4039	830.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2545	2545	C	894	C,G	893,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26890	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4039	830.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2619	2619	A	804	A,G,T	802,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26890	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4039	830.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3171	3171	C	967	C,A	964,3	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26890	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4039	830.4	0	HET	.	.	.	C2403T,A,G	.	2403	2403	C	2977	2977	C	868	C,T,A,G	685,179,3,1	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2324	folP	855	855	100.0	folP.l15.c4.ctg.1	2138	135.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1333	1335	AGC	230;228;228	A;G;C,A	230;228;227,1	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5418	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3764	179.4	1	SNP	p	S91F	1	.	.	271	273	TTC	763	765	TTC	207;204;203	T;T,G;C	207;203,1;203	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5418	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3764	179.4	1	SNP	p	G95N	0	.	.	283	285	GGC	775	777	GGC	211;211;211	G;G;C,T	211;211;210,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5418	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3764	179.4	1	SNP	p	D95G	1	.	.	283	285	GGC	775	777	GGC	211;211;211	G;G;C,T	211;211;210,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	2078	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1828	141.9	1	SNP	p	G45D	0	.	.	133	135	GGC	734	736	GGC	257;258;260	G;G;C,T	257;258;259,1	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1174	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1387	105.5	0	.	n	.	0	A197.	DEL	197	197	A	748	748	A	237	A	237	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5320	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3510	189.0	1	SNP	p	D86N	0	.	.	256	258	GAC	899	901	GAC	238;241;236	G,C;A;C	237,1;241;236	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5320	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3510	189.0	1	SNP	p	S87R	1	.	.	259	261	CGT	902	904	CGT	236;237;242	C;G;T	236;237;241	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5320	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3510	189.0	1	SNP	p	R87I	0	.	.	259	261	CGT	902	904	CGT	236;237;242	C;G;T	236;237;241	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5320	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3510	189.0	1	SNP	p	R87W	0	.	.	259	261	CGT	902	904	CGT	236;237;242	C;G;T	236;237;241	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5320	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3510	189.0	1	SNP	p	S88P	0	.	.	262	264	TCC	905	907	TCC	240;239;238	T;C,A;C	239;238,1;238	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4534	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3178	177.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1843	1845	GGC	229;232;230	G;G;C,A	229;232;229,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4198	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2790	187.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1451	1453	GCA	236;238;236	G;C;A	236;238;236	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4198	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2790	187.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1454	1456	ATC	233;233;232	A;T;C	233;233;232	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4198	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2790	187.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1466	1468	GTG	228;229;236	G;T;G	228;229;236	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4198	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2790	187.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1466	1468	GTG	228;229;236	G;T;G	228;229;236	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4198	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2790	187.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1970	1972	ACC	264;263;266	A,T;C,A,T;C,T,A	263,1;261,1,1;264,1,1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4198	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2790	187.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2024	2026	GCG	227;228;229	G;C,G;G	227;227,1;229	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4198	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2790	187.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2024	2026	GCG	227;228;229	G;C,G;G	227;227,1;229	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4198	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2790	187.2	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2147	2149	AGC	233;233;233	A,G;G;C	232,1;233;233	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4198	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2790	187.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2156	2158	GGC	239;239;238	G;G;C,G	239;239;237,1	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4198	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2790	187.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2174	2176	CCG	232;239;237	C,A,G;C;G,T,C	228,2,2;239;235,1,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5858	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3500	208.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1800	1802	CCG	246;248;249	C,A;C;G	245,1;248;249	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2618	porA	1146	1146	99.91	porA.l6.c30.ctg.1	2284	142.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	832	832	C	225	C	225	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	366	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	604	32.0	0	.	p	.	0	S271T	NONSYN	811	813	TCG	62	64	ACT	101;101;101	A;C;T,G	101;101;100,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	366	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	604	32.0	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	68	70	GAT	101;101;101	G;A;T	101;101;101	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	366	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	604	32.0	0	.	p	.	0	D274S	NONSYN	820	822	GAT	71	73	AGT	101;101;101	A;G;T	101;101;101	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	366	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	604	32.0	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	80	82	TAC	101;101;101	T;A;C	101;101;101	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	366	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	604	32.0	0	.	p	.	0	R307E	NONSYN	919	921	AGA	170	172	GAA	5;5;5	G;A;A	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	366	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	604	32.0	0	.	p	.	0	T311A	NONSYN	931	933	ACA	182	184	GCA	4;5;5	G;C;A	4;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	366	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	604	32.0	0	.	p	.	0	E312D	NONSYN	934	936	GAA	185	187	GAC	5;5;6	G;A;C	5;5;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	366	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	604	32.0	0	.	p	.	0	F314I	NONSYN	940	942	TTC	191	193	ATC	8;8;9	A;T;C	8;8;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	366	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	604	32.0	0	.	p	.	0	A316S	NONSYN	946	948	GCG	197	199	TCG	9;9;9	T;C;G	9;9;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	366	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	604	32.0	0	.	p	.	0	V318A	NONSYN	952	954	GTC	203	205	GCC	10;10;10	G;C;C	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	366	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	604	32.0	0	.	p	.	0	G319S	NONSYN	955	957	GGC	206	208	AGC	10;10;10	A;G;C	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	366	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	604	32.0	0	.	p	.	0	G320A	NONSYN	958	960	GGT	209	211	GCC	10;10;10	G;C;C	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	366	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	604	32.0	0	.	p	.	0	G322V	NONSYN	964	966	GGT	215	217	GTT	10;11;11	G;T;T	10;11;11	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	0	.	p	.	0	E48G	NONSYN	142	144	GAA	583	585	GGA	246;246;246	G;G;A	246;246;246	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	0	.	p	.	0	V75I	NONSYN	223	225	GTT	664	666	ATT	274;267;267	A;T;T	274;267;267	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	0	.	p	.	0	T89S	NONSYN	265	267	ACC	706	708	AGC	261;262;259	A;G;C	261;262;259	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	0	.	p	.	0	V98I	NONSYN	292	294	GTC	733	735	ATC	243;239;238	A,C;T,G;C	242,1;238,1;238	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	0	.	p	.	0	.	MULTIPLE	358	359	AA	798	799	CG	217;216	C;G	217;216	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	0	.	p	.	0	.	MULTIPLE	361	362	GA	801	803	CAG	218;219;222	C;A;G	218;219;222	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	0	.	p	.	0	N122K	NONSYN	364	366	AAC	805	807	AAA	219;220;221	A;A,C;A	219;219,1;221	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	832	834	TAT	242;243;244	T,G;A;T	241,1;243;244	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	0	.	p	.	0	N134E	NONSYN	400	402	AAT	841	843	GAG	253;255;254	G,T,A;A;G	250,2,1;255;254	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	0	.	p	.	0	V135L	NONSYN	403	405	GTG	844	846	CTT	252;256;257	C;T,G;T,G	252;255,1;256,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	0	.	p	.	0	G140K	NONSYN	418	420	GGA	859	861	AAA	254;255;256	A;A;A	254;255;256	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	0	.	p	.	0	K143E	NONSYN	427	429	AAA	868	870	GAA	257;256;255	G,C;A,G;A	256,1;255,1;255	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	0	.	p	.	0	V151A	NONSYN	451	453	GTA	892	894	GCA	264;265;262	G,A;C;A,T	263,1;265;261,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	0	.	p	.	0	A196V	NONSYN	586	588	GCC	1027	1029	GTC	282;280;280	G,T;T,G,A;C	281,1;278,1,1;280	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	0	.	p	.	0	T213S	NONSYN	637	639	ACA	1078	1080	TCA	278;278;278	T,G;C,T,A;A	275,2;274,2,1;277	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	1198	1200	CAA	197;200;199	C;A,C;A	197;199,1;199	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	0	.	p	.	0	.	INDELS	760	762	ACA	1202	1206	ATCAA	194;191;190;188;191	A;T;C;A;A	194;191;190;188;191	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	0	.	p	.	0	.	INDELS	763	764	TG	1209	1211	AGT	191;191;190	A;G;T	191;191;190	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	0	.	p	.	0	A257D	NONSYN	769	771	GCT	1216	1218	GAT	198;199;200	G,T;A;T	196,2;199;200	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	0	.	p	.	0	T269S	NONSYN	805	807	ACC	1252	1254	AGC	216;217;219	A;G;C	216;217;219	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1324	1326	AGT	263;264;266	A;G;T	263;264;266	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1330	1332	GAC	272;269;274	G;A;C	272;269;274	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	0	.	p	.	0	H296Y	NONSYN	886	888	CAC	1333	1335	TAC	277;275;280	T;A;C	277;275;280	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	1	SNP	p	G120K	1	.	.	358	360	AAG	798	800	CGG	217;216;217	C;G;G	217;216;217	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	1	SNP	p	D121N	0	.	.	361	363	GAC	801	804	CGC	218;222;224	C;G;C	218;222;224	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2892	porB1b	1041	1041	96.28	porB1b.l15.c17.ctg.1	1825	195.9	1	SNP	p	A121D	1	.	.	361	363	GAC	801	804	CGC	218;222;224	C;G;C	218;222;224	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	290	porB3	990	161	93.79	porB3.l15.c4.ctg.4	163	76.7	0	.	p	.	0	S273T	NONSYN	817	819	TCG	62	64	ACT	100;100;100	A;C;T,G	100;100;99,1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	290	porB3	990	161	93.79	porB3.l15.c4.ctg.4	163	76.7	0	.	p	.	0	D276S	NONSYN	826	828	GAT	71	73	AGT	100;100;100	A;G;T	100;100;100	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	290	porB3	990	161	93.79	porB3.l15.c4.ctg.4	163	76.7	0	.	p	.	0	K278D	NONSYN	832	834	AAA	77	79	GAC	100;100;100	G;A;C	100;100;100	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	290	porB3	990	161	93.79	porB3.l15.c4.ctg.4	163	76.7	0	.	p	.	0	R279Y	NONSYN	835	837	CGC	80	82	TAC	100;100;100	T;A;C	100;100;100	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10644	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5442	243.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1608	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1336	149.6	1	SNP	p	V57M	1	.	.	169	171	ATG	698	700	ATG	275;277;276	A;T;G	275;277;276	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
